Alnylam Pharmaceuticals
ALNY
#587
Rank
NZ$60.33 B
Marketcap
$467.79
Share price
0.12%
Change (1 day)
55.62%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company